Table 3.
Study characteristics of corticosteroid treatment of adhesive capsulitis. a
| Study | Type | Patients, n | Follow-up, wk | Treatment Arm | Control Arm | Outcomes Measures |
|---|---|---|---|---|---|---|
| Arlsan4 | RCT | 20 | 2, 12 | 40 mg, methylprednisolone | NSAIDs, PT | VAS, ROM |
| Blanchard8 | SR | 362 | Up to 52 | Triamcinolone or methylprednisolone | PT | VAS, ROM, SPADI, SF-36 |
| de Jong18 | RCT | 25 | 1,3,6 | 40 mg, triamcinolone | 10 mg, triamcinolone | Pain, sleep disturbance |
| Griesser24 | SR | 409 | Up to 52 | Triamcinolone or methylprednisolone | PT, oral steroid, manipulation, ice pack, no treatment | SPADI, VAS, SF-36, ROM |
| Rizk48 | RCT | 48 | 3 | 40 mg, methylprednisolone | Lidocaine, PT | Pain, ROM |
| van der Windt57 | RCT | 109 | 3, 7, 13, 26, 52 | 40 mg, triamcinolone (no more than 3 injections) | 12 sessions of PT | VAS day and night, passive lateral rotation and abduction |
a
RCT, randomized controlled trial; SR, systematic review; NSAIDs, nonsteroidal anti-inflammatory drugs; PT, physical therapy; VAS, visual analog scale; ROM, range of motion; SPADI, Shoulder Pain and Disability Index.